Tag:
heart disease
Latest Headlines
Latest Headlines
UPDATED: New cloud hovers over class of 'good cholesterol' drugs
Fresh doubts have cropped up for raising "good cholesterol" to combat heart attack risk, after a new study showed that patients genetically programmed to have higher levels of HDL cholesterol didn't appear to be more protected from heart disease than those with low levels.
UPDATED: Mobile apps could rival pharma's crown jewels
As we pack more data about our health into mobile devices, pharma companies could face a new competitive threat to their drugs: Mobile health apps.
Frontage to manufacture atherosclerosis drug
The PA-based CRO was picked by biotech AtheroNova to develop clinical trial supplies in preparation for a Phase I clinical trial for an atherosclerosis drug.
Medtronic to launch global trial for drug-eluting balloon
On the heels of starting American trials for its drug-eluting balloon, Medtronic is taking studies of its delivery device global.
Study: DNA sequencing dubious as disease prevention tool
DNA sequencing may not be so useful after all for determining future health risks and ways to prevent them, according to a new Johns Hopkins University study.
Pozen shares jump on promising outcome for PhIII studies
Pozen's stock surged 19% after it announced positive data for its amped-up aspirin.
Pioneering stem cell therapy mends damaged heart tissue in patients
Score one small victory for the troubled field of stem cell therapeutics. A small clinical trial showed that patients' own stem cells could repair damaged heart tissue after they suffered heart
Experts debate preventive use of statins
No question, the cholesterol-fighting statin drugs have been a powerhouse class for Big Pharma. One of them--Pfizer's ( $PFE ) Lipitor --was the best-selling branded medication of all time, and plenty
Altering intestinal bacteria with probiotics improved rats' heart health
Probiotics--a crucial ingredient in yogurt and supplements that promotes healthy digestion--could someday play a role in helping to prevent and treat heart attacks. A new finding by study author John
Study flags risk of heart attack, ACS in Pradaxa patients
Another blow to Pradaxa 's prospects: The Boehringer Ingelheim blood thinner has been associated with an increased risk of heart attack. In a new study, Cleveland Clinic researchers found that Pradaxa
